Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder [11]

Evdokia Anagnostou, Katherine Esposito, Latha Soorya, William Chaplin, Stacey Wasserman, Eric Hollander

Research output: Contribution to journalArticle

25 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)444-446
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume26
Issue number4
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Irritable Mood
Second-Generation Antidepressive Agents
Antimanic Agents
Fluoxetine
Valproic Acid
Autistic Disorder
Double-Blind Method
Placebos
Therapeutics
Autism Spectrum Disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder [11]. / Anagnostou, Evdokia; Esposito, Katherine; Soorya, Latha; Chaplin, William; Wasserman, Stacey; Hollander, Eric.

In: Journal of Clinical Psychopharmacology, Vol. 26, No. 4, 08.2006, p. 444-446.

Research output: Contribution to journalArticle

Anagnostou, Evdokia ; Esposito, Katherine ; Soorya, Latha ; Chaplin, William ; Wasserman, Stacey ; Hollander, Eric. / Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder [11]. In: Journal of Clinical Psychopharmacology. 2006 ; Vol. 26, No. 4. pp. 444-446.
@article{d4d0a9364f7040a19928acd7e055f191,
title = "Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder [11]",
author = "Evdokia Anagnostou and Katherine Esposito and Latha Soorya and William Chaplin and Stacey Wasserman and Eric Hollander",
year = "2006",
month = "8",
doi = "10.1097/01.jcp.0000227703.72117.bc",
language = "English (US)",
volume = "26",
pages = "444--446",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder [11]

AU - Anagnostou, Evdokia

AU - Esposito, Katherine

AU - Soorya, Latha

AU - Chaplin, William

AU - Wasserman, Stacey

AU - Hollander, Eric

PY - 2006/8

Y1 - 2006/8

UR - http://www.scopus.com/inward/record.url?scp=33746929827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746929827&partnerID=8YFLogxK

U2 - 10.1097/01.jcp.0000227703.72117.bc

DO - 10.1097/01.jcp.0000227703.72117.bc

M3 - Article

C2 - 16855475

AN - SCOPUS:33746929827

VL - 26

SP - 444

EP - 446

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 4

ER -